Camber Pharmaceuticals continues to expand its portfolio of HIV treatments with the addition of 800 mg Darunavir Tablets [da-ROON-a-veer], supplied in bottles of 30.
This new strength joins Camber’s previously launched 600 mg Darunavir Tablets, introduced two years ago. Darunavir Tablets are the generic equivalent of Prezista®.
Darunavir Tablets co-administered with ritonavir (darunavir tablets/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adult and pediatric patients 3 years of age and older.
To learn more about this product, visit: www.camberpharma.com/darunavir
